cigna glp 1 2025 Evernorth expands program to help employers curb GLP-1 costs Weight loss drugs' high costs

2024;132(4):S01616420(24)006857

These people are not recommended by the FDA to take GLP-1 medications

Current guidelines do not recommend combination therapy with GLP-1 RAs and DPP-4 inhibitors, and the ADA/EASD consensus report specifically recommends discontinuation of DPP-4 inhibitors when initiating GLP-1 RA therapy

After the first use, Ozempic can be stored at room temperature for up to 56 days

Mounjaro is suitable for: Overweight or obese Have type 2 diabetes or insulin resistance Struggle with frequent hunger, cravings, or portion control Weight-related concerns such as high blood pressure or high cholesterol Committed to lifestyle changes, nutrition guidance, and follow-ups with doctors Mounjaro is NOT suitable for: Mounjaro is not for everyone because it affects your digestion, blood sugar response, and especially for those with medical conditions